Surge in specialty drug use ‘largely driven’ by autoimmune disease

Autoimmune treatments accounted for more than half of all specialty drug use in 2021, according to a drug trend report released by CVS Health.
The report, published in late February, covers year-to-date Q3 2021 cost savings and trend data based on performance for commercial clients of CVS Health’s pharmacy benefit manager (PBM), CVS Caremark.
“In 2021, specialty growth was largely driven by utilization increases of specialty treatments in certain categories, including autoimmune and asthma/atopic dermatitis,” the report states, in part. “The increase in utilization was

Autoimmune treatments accounted for more than half of all specialty drug use in 2021, according to a drug trend report released by CVS Health.
The report, published in late February, covers year-to-date Q3 2021 cost savings and trend data based on performance for commercial clients of CVS Health’s pharmacy benefit manager (PBM), CVS Caremark.
“In 2021, specialty growth was largely driven by utilization increases of specialty treatments in certain categories, including autoimmune and asthma/atopic dermatitis,” the report states, in part. “The increase in utilization was